Person profile
Public information reviewedLeonard S. Schleifer, M.D., Ph.D.
Role
Board co-Chair, President and Chief Executive Officer at Regeneron Pharmaceuticals (NASDAQ: REGN)
Regeneron Pharmaceuticals (NASDAQ: REGN)
Board co-Chair, President and Chief Executive Officer · Current mandate
- Public sources
- 1 reviewed
- Profile ownership
- Not yet claimed
- Last reviewed
- Sep 14, 2026
Alpha Registry